The effectiveness of nonpharmacological interventions for informal dementia caregivers: An updated systematic review and meta-analysis.
This systematic review and meta-analysis compared the effects of 131 randomized
controlled trials, published between 2006 and mid-2018, for dementia caregivers with …
controlled trials, published between 2006 and mid-2018, for dementia caregivers with …
A meta-review of stress, co** and interventions in dementia and dementia caregiving
Background There has been a substantial number of systematic reviews of stress, co**
and interventions for people with dementia and their caregivers. This paper provides a meta …
and interventions for people with dementia and their caregivers. This paper provides a meta …
Interventions with family caregivers of cancer patients: meta‐analysis of randomized trials
Family caregivers of cancer patients receive little preparation, information, or support to
perform their caregiving role. However, their psychosocial needs must be addressed so they …
perform their caregiving role. However, their psychosocial needs must be addressed so they …
Psychosocial care for family caregivers of patients with cancer
Purpose To understand family caregivers' needs for better preparation and care, this state-of-
the-science review examines the effect of caregiving on the health and well-being of …
the-science review examines the effect of caregiving on the health and well-being of …
Family caregiving of persons with dementia: prevalence, health effects, and support strategies
R Schulz, Hel** caregivers of persons with dementia: which interventions work and how large are their effects?
M Pinquart, S Sörensen - International psychogeriatrics, 2006 - cambridge.org
Background: In recent years, many different forms of interventions for caregivers of people
with dementia have been developed. However, their results have been, in part, inconclusive …
with dementia have been developed. However, their results have been, in part, inconclusive …
[HTML][HTML] Lecanemab clarity AD: quality-of-life results from a randomized, double-blind phase 3 trial in early Alzheimer's disease
S Cohen, CH van Dyck, M Gee, T Doherty… - The Journal of …, 2023 - Elsevier
Background Lecanemab is a humanized IgG1 monoclonal antibody binding with high affinity
to amyloid-beta protein protofibrils. In phase 3 development, lecanemab has been shown to …
to amyloid-beta protein protofibrils. In phase 3 development, lecanemab has been shown to …